GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants In Vitro

অনুরূপ উপাদানগুলি

• GRL-04810 and GRL-05010, Difluoride-Containing Nonpeptidic HIV-1 Protease Inhibitors (PIs) That Inhibit the Replication of Multi-PI-Resistant HIV-1 In Vitro and Possess Favorable Lipophilicity That May Allow Blood-Brain Barrier Penetration
  অনুযায়ী: Salcedo Gómez, Pedro Miguel, অন্যান্য
  প্রকাশিত: (2013)
• Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants
  অনুযায়ী: Hattori, Shin-ichiro, অন্যান্য
  প্রকাশিত: (2019)
• A Novel Tricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor, GRL-0739, Effectively Inhibits the Replication of Multidrug-Resistant HIV-1 Variants and Has a Desirable Central Nervous System Penetration Property In Vitro
  অনুযায়ী: Amano, Masayuki, অন্যান্য
  প্রকাশিত: (2015)
• GRL-02031, a Novel Nonpeptidic Protease Inhibitor (PI) Containing a Stereochemically Defined Fused Cyclopentanyltetrahydrofuran Potent against Multi-PI-Resistant Human Immunodeficiency Virus Type 1 In Vitro
  অনুযায়ী: Koh, Yasuhiro, অন্যান্য
  প্রকাশিত: (2009)
• Probing multidrug-resistance/protein-ligand interaction with oxatricyclic designed ligands in HIV-1 Protease inhibitors
  অনুযায়ী: Ghosh, Arun K., অন্যান্য
  প্রকাশিত: (2010)